Latest News for: Ovid

Edit

Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results (Form 8-K) (Ovid Therapeutics Inc)

Public Technologies 12 May 2026
) Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results ... NEW YORK, May 12, 2026 - Ovid Therapeutics Inc ... Ovid anticipates initiating the Phase 2 study in the second quarter of 2026 ... About Ovid Therapeutics.
Edit

May 2026 Corporate Presentation (Ovid Therapeutics Inc)

Public Technologies 12 May 2026
© Copyright 2026 Ovid Therapeutics ... © Copyright 2026 Ovid Therapeutics 3 ... © Copyright 2026 Ovid Thera. © Copyright 2026 Ovid Therapeutics 6 ... Ovid data on file ... © Copyright 2026 Ovid Therapeutics ... Ovid Therapeutics Inc.
Edit

Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) (Ovid Therapeutics Inc)

Public Technologies 12 May 2026
) Management's Discussion and Analysis of Financial Condition and Results of Operations ... Please also see the section entitled "Special Note Regarding Forward-Looking Statements.". Overview ... Our Pipeline ... Revenue ... Revenue. ... Ovid Therapeutics Inc.
Edit

How Ancient Greece Shaped Ovid, Rome’s Master Poet

Greek Reporter 10 May 2026
Statue of Ovid in Constanța, Romania ... If we took ancient Greece out of the equation, the Ovid we celebrate and admire today wouldn’t exist ... Never mind the Tiber River—Ovid’s poetic inspiration was undeniably the Aegean Sea.
Edit

The Kalends of May: How Rome Opened a Sacred Month of Fire, Growth, and Old Gods

Roman Empire Times 02 May 2026
Lowrey)Ovid and the Ritual Opening of a New Month ... As Ovid puts it,“You ask whence I suppose the name of the month of May to be derived.” ... Ovid’s poem repeatedly shows that rites are introduced, explained, and imaginatively staged.
Edit

Additional Proxy Soliciting Materials (Form DEFA14A) (Ovid Therapeutics Inc)

Public Technologies 27 Apr 2026
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. ______________________________________________________. SCHEDULE 14A. Proxy Statement Pursuant to Section 14(a) of the ... (Amendment No. ) ... Ovid Therapeutics Inc ... Ovid Therapeutics Inc.
Edit

Annual Report (Form ARS) (Ovid Therapeutics Inc)

Public Technologies 27 Apr 2026
). The text version of this document is not available ... Ovid Therapeutics Inc.
Edit

Supplemental Prospectus (Form 424B3) (Ovid Therapeutics Inc)

Public Technologies 27 Apr 2026
Our common stock is listed on The Nasdaq Capital Market under the trading symbol "OVID." On April 24, 2026, the last reported sale price of the common stock was $2.60 per share ... Nasdaq Capital Market symbol "OVID".
Edit

Proxy Statement (Form DEF 14A) (Ovid Therapeutics Inc)

Public Technologies 27 Apr 2026
Ovid Therapeutics Inc ... On behalf of the Board of Directors and the employees of Ovid, we appreciate your investment in Ovid and urge you to cast your vote as soon as possible ... You may also access additional information about Ovid Therapeutics Inc.
Edit

Walk for the Red 5K returns to Ovid-Elsie to aid firefighters with cancer

The Argus Press 24 Apr 2026
ELSIE — The Walk for the Red Memorial 5K race, which raises funds and awareness for Michigan firefighters battling cancer, is returning to the Ovid-Elsie area for a second year ... .
Edit

Ovid expanding events with market, art walk

The Argus Press 22 Apr 2026
OVID — Two months after launching its first-ever chocolate walk, the city of Ovid is building on the momentum with plans underway for a farmer’s market and art walk aimed at bringing more life to the city ... .
Edit

Registration Statement - Specified Transactions (Form S-3) (Ovid Therapeutics Inc)

Public Technologies 21 Apr 2026
Ovid Therapeutics Inc ... Ovid Therapeutics Inc ... Ovid Therapeutics Inc ... Our common stock is listed on The Nasdaq Capital Market under the symbol "OVID." We do not intend to list the Pre-Funded Warrants on any national securities exchange.
Edit

Material Event (Form 8-K) (Ovid Therapeutics Inc)

Public Technologies 20 Apr 2026
) Item 8.01 Other Events. On April 17, 2026, the Series A Warrants (the "Series A Warrants") issued by Ovid Therapeutics Inc ... Disclaimer. Ovid Therapeutics Inc ... (noodl. 131055298) .
×